Crossmark

eBIMIC: development of a web platform for real-time access to cumulative antimicrobial susceptibility reports and its potential impact on evidence-based antibiotic prescribing in bacteremia

Crossref DOI link: https://doi.org/10.1007/s10096-026-05413-8

Published Online: 2026-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hernández, Silvia

Colomina, Javier

Giménez, Estela

Medina, Andrea

Villarruel, Katherine

Albert, Eliseo

Navarro, David

Torres, Ignacio
License Information

Text and Data Mining valid from 2026-01-20

Version of Record valid from 2026-01-20
More Information

Article History

Received: 28 July 2025

Accepted: 8 January 2026

First Online: 20 January 2026

Declarations

:

: The current study was approved by the Research Ethics Committee of Hospital Clínico Universitario INCLIVA (September, 2019).

: The authors declare no competing interests.

: During the preparation of this work the authors used ChatGPT, a large language model developed by OpenAI, in order to assist with scientific writing. After using this tool/service, the authors reviewed and edited the content as needed and takes full responsibility for the content of the published article.

Document is current

Any future updates will be listed below